Skip to content

KMTS KMTS Increase (Decrease) in Accounts Receivable

Increase (Decrease) in Accounts Receivable at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
Haemonetics logo
HaemoneticsHAE
Corvex
 logo
Corvex MOVE

Other financials

Income statement

See full
Revenue$28.6M+66.2%
Gross profit$15.7M+105%
Operating income-$39.3M+18.4%
Net income-$38.8M+25.4%
EPS (diluted)-$0.67+57.3%

Balance sheet

See full
Cash & equivalents$99.7M-58.0%
Total debt$46.8M+5.6%
Total assets$358.5M+21.2%

Cash flow

See full
Operating cash flow-$18.7M+22.2%
CapEx$9.7M+30.8%
Free cash flow-$28.4M+9.7%

Valuation

See full
Market cap$1.4B+65.0%
Enterprise value$1.35B
P/S14.7×

Profitability

See full
Gross margin51.4%+10.9pp
Operating margin-141.6%-24.0pp
Net margin-138.4%-29.7pp
FCF margin-122.6%-26.1pp

Returns & leverage

See full
Current ratio4.4×-2.3×

Where this comes from

Reported directly by KMTS in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: KMTS’s 10-K, filed July 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about KMTS's increase (decrease) in accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KMTS's increase (decrease) in accounts receivable?
KMTS (KMTS) reported increase (decrease) in accounts receivable of $2.91M in Q1 2026.
How has KMTS's increase (decrease) in accounts receivable changed year-over-year?
KMTS's increase (decrease) in accounts receivable increased by 202.5% year-over-year, from $963K to $2.91M.
What is the long-term trend for KMTS's increase (decrease) in accounts receivable?
Over 2 years (2024 to 2026), KMTS's increase (decrease) in accounts receivable has grown at a 90.4% compound annual growth rate (CAGR), from $2.5M to $9.06M.